BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 33106477)

  • 21. Spindle and kinetochore-associated complex 3 promotes cell growth via the PI3K/AKT/GSK3β and PI3K/AKT/FOXO1 pathways and is a potential prognostic biomarker for oral squamous cell carcinoma.
    Xu H; Chen G; Niu Q; Song K; Feng Z; Han Z
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2022 Nov; 134(5):599-614. PubMed ID: 36123287
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Co-targeting PLK1 and mTOR induces synergistic inhibitory effects against esophageal squamous cell carcinoma.
    Liu TT; Yang KX; Yu J; Cao YY; Ren JS; Hao JJ; Pan BQ; Ma S; Yang LY; Cai Y; Wang MR; Zhang Y
    J Mol Med (Berl); 2018 Aug; 96(8):807-817. PubMed ID: 29959473
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA 744-3p promotes MMP-9-mediated metastasis by simultaneously suppressing PDCD4 and PTEN in laryngeal squamous cell carcinoma.
    Li JZ; Gao W; Lei WB; Zhao J; Chan JY; Wei WI; Ho WK; Wong TS
    Oncotarget; 2016 Sep; 7(36):58218-58233. PubMed ID: 27533461
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aurora kinase A revives dormant laryngeal squamous cell carcinoma cells via FAK/PI3K/Akt pathway activation.
    Yang LY; He CY; Chen XH; Su LP; Liu BY; Zhang H
    Oncotarget; 2016 Jul; 7(30):48346-48359. PubMed ID: 27356739
    [TBL] [Abstract][Full Text] [Related]  

  • 25. KLK11 acts as a tumor-inhibitor in laryngeal squamous cell carcinoma through the inactivation of Akt/Wnt/β-catenin signaling.
    Zhao R; Wang S; Liu J; Xu C; Zhang S; Shao Y; Duan X
    J Bioenerg Biomembr; 2021 Feb; 53(1):85-96. PubMed ID: 33420975
    [TBL] [Abstract][Full Text] [Related]  

  • 26. lncRNA CCAT1 is a biomarker for the proliferation and drug resistance of esophageal cancer via the miR-143/PLK1/BUBR1 axis.
    Hu M; Zhang Q; Tian XH; Wang JL; Niu YX; Li G
    Mol Carcinog; 2019 Dec; 58(12):2207-2217. PubMed ID: 31544294
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PLK1 promotes proliferation and suppresses apoptosis of renal cell carcinoma cells by phosphorylating MCM3.
    Gao Z; Man X; Li Z; Bi J; Liu X; Li Z; Li J; Zhang Z; Kong C
    Cancer Gene Ther; 2020 Jun; 27(6):412-423. PubMed ID: 31186514
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cervical Cancer Growth Is Regulated by a c-ABL-PLK1 Signaling Axis.
    Yang X; Chen G; Li W; Peng C; Zhu Y; Yang X; Li T; Cao C; Pei H
    Cancer Res; 2017 Mar; 77(5):1142-1154. PubMed ID: 27899378
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SKA3 Promotes tumor growth by regulating CDK2/P53 phosphorylation in hepatocellular carcinoma.
    Hou Y; Wang Z; Huang S; Sun C; Zhao J; Shi J; Li Z; Wang Z; He X; Tam NL; Wu L
    Cell Death Dis; 2019 Dec; 10(12):929. PubMed ID: 31804459
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Actin-like 6A enhances the proliferative and invasive capacities of laryngeal squamous cell carcinoma by potentiating the activation of YAP signaling.
    Dang Y; Zhang L; Wang X
    J Bioenerg Biomembr; 2020 Dec; 52(6):453-463. PubMed ID: 33067739
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Essential Role of Polo-like Kinase 1 (Plk1) Oncogene in Tumor Growth and Metastasis of Tamoxifen-Resistant Breast Cancer.
    Jeong SB; Im JH; Yoon JH; Bui QT; Lim SC; Song JM; Shim Y; Yun J; Hong J; Kang KW
    Mol Cancer Ther; 2018 Apr; 17(4):825-837. PubMed ID: 29437878
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long non-coding RNA CCAT2 drives the growth of laryngeal squamous cell carcinoma via regulating YAP activity.
    Zang Y; Li J; Wan B; Tai Y; Liu H; Li Q; Ji Y
    Hum Cell; 2021 Nov; 34(6):1878-1887. PubMed ID: 34515990
    [TBL] [Abstract][Full Text] [Related]  

  • 33. RBM15 facilitates laryngeal squamous cell carcinoma progression by regulating TMBIM6 stability through IGF2BP3 dependent.
    Wang X; Tian L; Li Y; Wang J; Yan B; Yang L; Li Q; Zhao R; Liu M; Wang P; Sun Y
    J Exp Clin Cancer Res; 2021 Feb; 40(1):80. PubMed ID: 33637103
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel tumor suppressor CECR2 down regulation links glutamine metabolism contributes tumor growth in laryngeal squamous cell carcinoma.
    Wang X; Xu C; Wang S; Huang W; Liu Y; Zhang X; Li N; Gao Z; Wang F; Zhang N; Guan J; Yi H; Liu F
    Clin Transl Oncol; 2021 Sep; 23(9):1942-1954. PubMed ID: 33826083
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long non‑coding RNA fer‑1‑like family member 4 serves as a tumor suppressor in laryngeal squamous cell carcinoma cells via regulating the AKT/ERK signaling pathway.
    Jiao L; Liu S; Liu L; Hao P; Gong Z; Yan Z; Xiang Y
    Mol Med Rep; 2020 Dec; 22(6):5304-5312. PubMed ID: 33174027
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TCTP protein degradation by targeting mTORC1 and signaling through S6K, Akt, and Plk1 sensitizes lung cancer cells to DNA-damaging drugs.
    Jeong M; Jeong MH; Kim JE; Cho S; Lee KJ; Park S; Sohn J; Park YG
    Sci Rep; 2021 Oct; 11(1):20812. PubMed ID: 34675258
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MiR-125b-5p suppressed the glycolysis of laryngeal squamous cell carcinoma by down-regulating hexokinase-2.
    Hui L; Zhang J; Guo X
    Biomed Pharmacother; 2018 Jul; 103():1194-1201. PubMed ID: 29864898
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of the PLK1-Coupled Cell Cycle Machinery Overcomes Resistance to Oxaliplatin in Colorectal Cancer.
    Yu Z; Deng P; Chen Y; Liu S; Chen J; Yang Z; Chen J; Fan X; Wang P; Cai Z; Wang Y; Hu P; Lin D; Xiao R; Zou Y; Huang Y; Yu Q; Lan P; Tan J; Wu X
    Adv Sci (Weinh); 2021 Dec; 8(23):e2100759. PubMed ID: 34881526
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sepsis induces muscle atrophy by inhibiting proliferation and promoting apoptosis via PLK1-AKT signalling.
    Cao YY; Wang Z; Yu T; Zhang Y; Wang ZH; Lu ZM; Lu WH; Yu JB
    J Cell Mol Med; 2021 Oct; 25(20):9724-9739. PubMed ID: 34514712
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibiting PLK1 induces autophagy of acute myeloid leukemia cells via mammalian target of rapamycin pathway dephosphorylation.
    Tao YF; Li ZH; Du WW; Xu LX; Ren JL; Li XL; Fang F; Xie Y; Li M; Qian GH; Li YH; Li YP; Li G; Wu Y; Feng X; Wang J; He WQ; Hu SY; Lu J; Pan J
    Oncol Rep; 2017 Mar; 37(3):1419-1429. PubMed ID: 28184925
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.